Vistagen Therapeutics, Inc.: Form 8-K, filed Sep 11, 2026
Filed with the SEC on Sep 11, 2026 and accepted by EDGAR at Sep 10, 2026, 19:24 ET.
Items reported
- Item 5.07 Shareholder vote results
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001628280-26-061445. Last ingested by Listed: Oct 30, 2026, 17:32 ET. Listed shows no prices and gives no investment advice.